Clinical Trial Update: Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical trial evaluating atomoxetine in adolescents with coexisting ADHD and alcohol/substance use disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Attention Deficit Hyperactivity Disorder
• Substance Use Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Substance Use Disorders, Attention Deficit Hyperactivity Disorder | Phase 2 | Status: COMPLETED